SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036536
Filing Date
2020-11-12
Accepted
2020-11-12 16:08:32
Documents
91
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_immucellcorp.htm 10-Q 721432
2 CERTIFICATION f10q0920ex31_immucellcorp.htm EX-31 6702
3 CERTIFICATION f10q0920ex32_immucellcorp.htm EX-32 4316
  Complete submission text file 0001213900-20-036536.txt   4874165

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20200930.xml EX-101.INS 882254
5 XBRL SCHEMA FILE iccc-20200930.xsd EX-101.SCH 61462
6 XBRL CALCULATION FILE iccc-20200930_cal.xml EX-101.CAL 66991
7 XBRL DEFINITION FILE iccc-20200930_def.xml EX-101.DEF 172242
8 XBRL LABEL FILE iccc-20200930_lab.xml EX-101.LAB 427661
9 XBRL PRESENTATION FILE iccc-20200930_pre.xml EX-101.PRE 324667
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 201306680
SIC: 2835 In Vitro & In Vivo Diagnostic Substances